Related Experiment Videos
Recent advances in vaccine adjuvants
Manmohan Singh1, Derek T O'Hagan
1Immunology and Infectiuos Disease, Chiron Corporation, Emeryville, California 94608, USA. manmohan_singh@chiron.com
Pharmaceutical Research
|July 24, 2002
Summary
New vaccine adjuvants are crucial as next-generation vaccines are less immunogenic. Developing potent adjuvants could lead to effective vaccines against cancer, infectious diseases, and mucosal delivery.
Area of Science:
- Immunology
- Vaccinology
Background:
- New vaccines (recombinant protein, DNA) show reduced immunogenicity compared to traditional ones.
- There is a critical need for advanced vaccine adjuvants to enhance immune responses.
Purpose of the Study:
- To explore the development and potential of novel vaccine adjuvants.
- To understand how adjuvants can improve vaccine efficacy and delivery.
Main Methods:
- Categorization of adjuvants into delivery systems (particulate) and immunostimulatory agents (pathogen-derived).
- Investigation of innate immunity pathways activated by immunostimulatory adjuvants, such as pathogen-associated molecular patterns.
Main Results:
- Adjuvants are classified by mechanism: delivery systems targeting antigen-presenting cells and immunostimulatory adjuvants activating innate immunity.
- Progress in understanding innate immunity offers insights into adjuvant mechanisms for enhancing immune initiation.
Conclusions:
- Potent new adjuvants are essential for developing effective prophylactic and therapeutic vaccines against cancers and chronic infectious diseases.
- Novel adjuvants may also facilitate mucosal vaccine delivery, expanding vaccination strategies.